Core Outcome Set-STAndards for Reporting: The COS-STAR Statement

被引:496
作者
Kirkham, Jamie J. [1 ]
Gorst, Sarah [1 ]
Altman, Douglas G. [2 ]
Blazeby, Jane M. [3 ]
Clarke, Mike [4 ]
Devane, Declan [5 ,6 ]
Gorgon, Elizabeth [1 ]
Moher, David [7 ]
Schmitt, Jochen [8 ]
Tugwell, Peter [9 ]
Tunis, Sean [10 ]
Williamson, Paula R. [1 ]
机构
[1] Univ Liverpool, Dept Biostat, MRC North West Hub Trials Methodol Res, Liverpool, Merseyside, England
[2] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[3] Univ Bristol, Sch Social & Community Med, MRC ConDuCT II Hub Trials Methodol Res, Bristol, Avon, England
[4] Queens Univ Belfast, Ctr Publ Hlth, Northern Ireland Hub Trials Methodol Res, Belfast, Antrim, North Ireland
[5] Natl Univ Ireland Galway, Galway, Ireland
[6] HRB Trials Methodol Res Network, Galway, Ireland
[7] Ottawa Hosp, Res Inst, Ottawa Methods Ctr, Ottawa, ON, Canada
[8] Tech Univ Dresden, Fak Med, Ctr Evidence Based Healthcare, Dresden, Germany
[9] Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada
[10] Ctr Med Technol Policy, Baltimore, MD USA
关键词
CLINICAL-TRIALS; ASTHMA; ECZEMA;
D O I
10.1371/journal.pmed.1002148
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background Core outcome sets (COS) can enhance the relevance of research by ensuring that outcomes of importance to health service users and other people making choices about health care in a particular topic area are measured routinely. Over 200 COS to date have been developed, but the clarity of these reports is suboptimal. COS studies will not achieve their goal if reports of COS are not complete and transparent. Methods and Findings In recognition of these issues, an international group that included experienced COS developers, methodologists, journal editors, potential users of COS (clinical trialists, systematic reviewers, and clinical guideline developers), and patient representatives developed the Core Outcome Set-STAndards for Reporting (COS-STAR) Statement as a reporting guideline for COS studies. The developmental process consisted of an initial reporting item generation stage and a two-round Delphi survey involving nearly 200 participants representing key stakeholder groups, followed by a consensus meeting. The COS-STAR Statement consists of a checklist of 18 items considered essential for transparent and complete reporting in all COS studies. The checklist items focus on the introduction, methods, results, and discussion section of a manuscript describing the development of a particular COS. A limitation of the COS-STAR Statement is that it was developed without representative views of low-and middle-income countries. COS have equal relevance to studies conducted in these areas, and, subsequently, this guideline may need to evolve over time to encompass any additional challenges from developing COS in these areas. Conclusions With many ongoing COS studies underway, the COS-STAR Statement should be a helpful resource to improve the reporting of COS studies for the benefit of all COS users.
引用
收藏
页数:11
相关论文
共 18 条
[1]
Brookes S, 2015, TRIALS S2, V16, P51
[2]
Asthma outcomes workshop: Overview [J].
Busse, William W. ;
Morgan, Wayne J. ;
Taggart, Virginia ;
Togias, Alkis .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (03) :S1-S8
[3]
Clarke M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0188-6
[4]
Committee for Medicinal Products for Human Use (CHMP), 2015, CHMPEWP292201
[5]
Choosing Important Health Outcomes for Comparative Effectiveness Research: A Systematic Review [J].
Gargon, Elizabeth ;
Gurung, Binu ;
Medley, Nancy ;
Altman, Doug G. ;
Blazeby, Jane M. ;
Clarke, Mike ;
Williamson, Paula R. .
PLOS ONE, 2014, 9 (06)
[6]
Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey [J].
Gorst, Sarah L. ;
Gargon, Elizabeth ;
Clarke, Mike ;
Blazeby, Jane M. ;
Altman, Douglas G. ;
Williamson, Paula R. .
PLOS ONE, 2016, 11 (01)
[7]
COS-STAR: a reporting guideline for studies developing core outcome sets (protocol) [J].
Kirkham, Jamie J. ;
Gorst, Sarah ;
Altman, Douglas G. ;
Blazeby, Jane ;
Clarke, Mike ;
Devane, Declan ;
Gargon, Elizabeth ;
Williamson, Paula R. .
TRIALS, 2015, 16
[8]
Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]
[9]
Schulz Kenneth F, 2010, Open Med, V4, pe60, DOI [10.1136/bmj.c869, 10.1016/j.jclinepi.2010.03.004, 10.1016/j.ijsu.2011.10.001]
[10]
Guidance for Developers of Health Research Reporting Guidelines [J].
Moher, David ;
Schulz, Kenneth F. ;
Simera, Iveta ;
Altman, Douglas G. .
PLOS MEDICINE, 2010, 7 (02)